Vivimed Labs Ltd. Thursday said it acquired Uquifa, a maker of active pharmaceutical ingredients and intermediates with operations in Spain and Mexico.
Vivimed, a maker of pharmaceutical formulations, didn’t give financial details of the deal, but said the move is aimed at expanding its footprint in Europe and the Americas.
Uquifa is the pharmaceutical division of U.K.-based Yule Catto PLC and operates two manufacturing sites in Spain and one in Mexico, its website showed.
Uquifa will become the active pharmaceutical ingredients, or API division, of the Vivimed group, Vivimed said in a regulatory filing.
Source: WSJ